[Clinical evaluation of the use of somatostatin (VAL 787) in the treatment of upper digestive hemorrhage]

Minerva Dietol Gastroenterol. 1989 Oct-Dec;35(4):261-4.
[Article in Italian]

Abstract

Personal experience with 30 patients treated with Somatostatin for upper gastrointestinal bleeding is reported. The conclusion is drawn that this drug, reducing chloro-peptic secretion and hepatic portal blood flow, can reduce and control bleeding and postpone the surgical operation, which has a high rate of mortality.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Drug Evaluation
  • Duodenal Ulcer / complications
  • Esophageal and Gastric Varices / complications
  • Female
  • Gastrointestinal Hemorrhage / drug therapy*
  • Gastrointestinal Hemorrhage / etiology
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Peptic Ulcer Hemorrhage / drug therapy
  • Peptic Ulcer Hemorrhage / etiology
  • Somatostatin / administration & dosage
  • Somatostatin / therapeutic use*
  • Stomach Ulcer / complications
  • Time Factors

Substances

  • Somatostatin